|
Apr 24
|
Strong sales for Cresemba® (isavuconazole) in Japan trigger second milestone payment from Asahi Kasei Pharma to Basilea
|
|
Jun 20
|
Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation
|
|
Jan 15
|
Basilea announces acquisition of preclinical antibiotics program from Spexis
|
|
Dec 20
|
Basilea announces accelerated loan repayment
|
|
Aug 4
|
Basilea announces submission of a New Drug Application to the US Food and Drug Administration for its antibiotic ceftobiprole
|